Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease

Genes, Brain and Behavior

Volumn 4, Issue 3, 2005, Pages 173-196

  Kobayashi, D T ^a   Chen, K S ^a  

^a ELAN PHARMACEUTICALS   (United States)

Author keywords

secretase; secretase; A ; Alzheimer's disease; Amyloid; APP; Behavior; Presenilin; Transgenic mouse models

Indexed keywords

ALPHA SECRETASE; AMYLOID PRECURSOR PROTEIN; AMYLOID PROTEIN; BETA SECRETASE; PRESENILIN 1; PRESENILIN 2; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ALZHEIMER DISEASE; AMNESIA; ANIMAL BEHAVIOR; ANIMAL MODEL; ASTROCYTOSIS; CAREGIVER; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEMENTIA; DNA MODIFICATION; INFLAMMATION; KNOCKOUT MOUSE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ENDOPEPTIDASES; BEHAVIOR, ANIMAL; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; ENDOPEPTIDASES; GENETICS, BEHAVIORAL; MEMBRANE PROTEINS; METALLOENDOPEPTIDASES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PHENOTYPE; PRESENILIN-1; PRESENILIN-2;

EID: 17644370721     PISSN: 16011848     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2005.00124.x     Document Type: Review

References (119)

1. Almkvist, O., Basun, H., Wagner, S.L., Rowe, B.A., Wahlund, L.O. & Lannfelt, L. (1997) Cerebrospinal fluid levels of alpha-secretase-cleaved soluble amyloid precursor protein mirror cognition in a Swedish family with Alzheimer disease and a gene mutation. Arch Neurol 54, 641-644.
2. Anderson, J.J., Holtz, G., Baskin, P.P., Wang, R., Mazzarelli, L., Wagner, S.L. & Menzaghi, F. (1999) Reduced cerebrospinal fluid levels of alpha-secretase-cleaved amyloid precursor protein in aged rats: correlation with spatial memory deficits. Neuroscience 93, 1409-1420.
3. Arendash, G.W. & King, D.L. (2002) Intra- and intertask relationships in a behavioral test battery given to Tg2576 transgenic mice and controls. Physiol Behav 75, 643-652.
4. Arendash, G.W., King, D.L., Gordon, M.N., Morgan, D., Hatcher, J.M., Hope, C.E. & Diamond, D.M. (2001) Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res 891, 42-53.
5. Askanas, V.E.W., Alvarez, R.B. & Glenner, G.G. (1992) Beta-amyloid protein immunoreactivity in muscle of patients with inclusion-body myositis. Lancet 29, 560-561.
6. Austin, L., Arendash, G.W., Gordon, M.N., Diamond, D.M., DiCarlo, G., Dickey, C., Ugen, K. & Morgan, D. (2003) Short-term beta-amyloid vaccinations do not improve cognitive performance in cognitively impaired APP + PS1 mice. Behav Neurosci 117, 478-484.
7. Beckmann, N., Schuler, A., Mueggler, T., Meyer, E.P., Wiederhold, K.H., Staufenbiel, M. & Krucker, T. (2003) Age-dependent cerebrovascular abnormalities and blood flow disturbances in APP23 mice modeling Alzheimer's disease. J Neurosci 23, 8453-8459.
8. Bednar, I., Paterson, D., Marutle, A., Pham, T.M., Svedberg, M., Hellstrom-Lindahl, E., Mousavi, M., Court, J., Morris, C., Perry, E., Mohammed, A., Zhang, X. & Nordberg, A. (2002) Selective nicotinic receptor consequences in APP (SWE) transgenic mice. Mol Cell Neurosci 20, 354-365.
9. Bernstein, H.G., Bukowska, A., Krell, D., Bogerts, B., Ansorge, S. & Lendeckel, U. (2003) Comparative localization of ADAMs 10 and 15 in human cerebral cortex normal aging, Alzheimer disease and down syndrome. J Neurocytol 32, 153-160.
10. Bondolfi, L., Calhoun, M., Ermini, F., Kuhn, H.G., Wiederhold, K.H., Walker, L., Staufenbiel, M. & Jucker, M. (2002) Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice. J Neurosci 22, 515-522.
11. Buxbaum, J.D., Liu, K.N., Luo, Y., Slack, J.L., Stocking, K.L., Peschon, J.J., Johnson, R.S., Castner, B.J., Cerretti, D.P. & Black, R.A. (1998) Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem 273, 27765-27767.
12. Cai, H., Wang, Y., McCarthy, D., Wen, H., Borchelt, D.R., Price, D.L. & Wong, P.C. (2001) BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci 4, 233-234.
13. Chapman, P.F., White, G.L., Jones, M.W., Cooper-Blacketer, D., Marshall, V.J., Irizarry, M., Younkin, L., Good, M.A., Bliss, T.V., Hyman, B.T., Younkin, S.G. & Hsiao, K.K. (1999) Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci 2, 271-276.
14. Chen, G., Chen, K.S., Knox, J., Inglis, J., Bernard, A., Martin, S.J., Justice, A., McConlogue, L., Games, D., Freedman, S.B. & Morris, R.G. (2000) A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature 408, 975-979.
15. Chen, K.S., Masliah, E., Grajeda, H., Guido, T., Huang, J., Khan, K., Motter, R., Soriano, F. & Games, D. (1998) Neurodegenerative Alzheimer-like pathology in PDAPP 717V→F transgenic mice. Prog Brain Res 117, 327-334.
16. Chishti, M.A., Yang, D.S., Janus, C. et al. (2001) Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 276, 21562-21570.
17. Colciaghi, F., Borroni, B., Pastorino, L., Marcello, E., Zimmermann, M., Cattabeni, F., Padovani, A. & Di Luca, M. (2002) [alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients. Mol Med 8, 67-74.
18. Corcoran, K.A., Lu, Y., Turner, R.S. & Maren, S. (2002) Over-expression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer's disease. Learn Mem 9, 243-252.
19. De Strooper, B. (2003) Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex. Neuron 38, 9-12.
20. De Strooper, B., Annaert, W., Cupers, P., Saftig, P., Craessaerts, K., Mumm, J.S., Schroeter, E.H., Schrijvers, V., Wolfe, M.S., Ray, W.J., Goate, A. & Kopan, R. (1999) A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398, 518-522.
21. DeMattos, R.B., Bales, K.R., Cummins, D.J., Dodart, J.C., Paul, S.M. & Holtzman, D.M. (2001) Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 98, 8850-8855.
22. Dewachter, I., Reverse, D., Caluwaerts, N., Ris, L., Kuiperi, C., Van den Haute, C., Spittaels, K., Umans, L., Serneels, L., Thiry, E., Moechars, D., Mercken, M., Godaux, E. & Van Leuven, F. (2002) Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice. J Neurosci 22, 3445-3453.
23. Dineley, K.T., Xia, X., Bui, D., Sweatt, J.D. & Zheng, H. (2002) Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins. J Biol Chem 277, 22768-22780.
24. Dodart, J.C., Bales, K.R., Gannon, K.S., Greene, S.J., DeMattos, R.B., Mathis, C., DeLong, C.A., Wu, S., Wu, X., Holtzman, D.M. & Paul, S.M. (2002) Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model. Nat Neurosci 5, 452-457.
25. Dodart, J.C., Mathis, C., Saura, J., Bales, K.R., Paul, S.M. & Ungerer, A. (2000) Neuroanatomical abnormalities in behaviorally characterized APP (V717F) transgenic mice. Neurobiol Dis 7, 71-85.
26. Dodart, J.C., Meziane, H., Mathis, C., Bales, K.R., Paul, S.M. & Ungerer, A. (1999) Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein. Behav Neurosci 113, 982-990.
27. Francis, R., McGrath, G., Zhang, J., Ruddy, D.A, Sym, M, Apfeld, J., Nicoll, M., Maxwell, M., Hai, B., Ellis, M.C., Parks, A.L., Xu, W., Li, J., Gurney, M., Myers, R.L., Himes, C.S., Hiebsch, R., Ruble, C., Nye, J.S. & Curtis, D. (2002) aph-1 and pen-2 are required for Notch pathway signaling, gammaα-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev Cell 3, 85-97.
28. Fukumoto, H., Cheung, B.S., Hyman, B.T. & Irizarry, M.C. (2002) Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol 59, 1381-1389.
29. Fukumoto, H., Rosene, D.L., Moss, M.B., Raju, S., Hyman, B.T. & Irizarry, M.C. (2004) Beta-secretase activity increases with aging in human, monkey, and mouse brain. Am J Pathol 164, 719-725.
30. Furukawa, K., Sopher, B.L., Rydel, R.E., Begley, J.G., Pham, D.G., Martin, G.M., Fox, M. & Mattson, M.P. (1996) Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J Neurochem 67, 1882-1896.
31. Games, D., Adams, D., Alessandrini, R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T. & Gillespie F. (1995) Alzheimer-type neuropathology in transgenic mice over-expressing V717F beta-amyloid precursor protein. Nature 373, 523-527.
32. Gerlai, R., Fitch, T., Bales, K.R. & Gitter, B.D. (2002) Behavioral impairment of APP(V717F) mice in fear conditioning: is it only cognition? Behav Brain Res 136, 503-509.
33. Glenner, G.G. & Wong, C.W. (1984) Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 122, 1131-1135.
34. Gonzalez-Lima, F., Berndt, J.D., Valla, J.E., Games, D. & Reiman, E.M. (2001) Reduced corpus callosum, fornix and hippocampus in PDAPP transgenic mouse model of Alzheimer's disease. Neuroreport 12, 2375-2379.
35. Gordon, M.N., King, D.L., Diamond, D.M., Jantzen, P.T., Boyett, K.V., Hope, C.E., Hatcher, J.M., DiCarlo, G., Gottschall, W.P., Morgan, D. & Arendash, G.W. (2001) Correlation between cognitive deficits and Abeta deposits in transgenic APP+PS1 mice. Neurobiol Aging 22, 377-385.
36. Hardy, J.A. & Higgins, G.A. (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184-185.
37. Harrison, S.M., Harper, A.J., Hawkins, J., Duddy, G., Grau, E., Pugh, P.L., Winter, P.H., Shilliam, C.S., Hughes, Z.A., Dawson, L.A., Gonzalez, M.I., Upton, N., Pangalos, M.N. & Dingwall, C. (2003) BACE1 (beta-secretase) transgenic and knockout mice: identification of neurochemical deficits and behavioral changes. Mol Cell Neurosci 24, 646-655.
38. Hartmann, D., de Strooper, B., Serneels, L., Craessaerts, K., Herreman, A., Annaert, W., Umans, L., Lubke, T., Lena Illert, A., von Figura, K. & Saftig, P. (2002) The disintegrin/metallo-protease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Hum Mol Genet 11, 2615-2624.
39. Haughey, N.J., Nath, A., Chan, S.L., Borchard, A.C., Rao, M.S. & Mattson, M.P. (2002) Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease. J Neurochem 83, 1509-1524.
40. Herreman, A., Hartmann, D., Annaert, W., Saftig, P., Craessaerts, K., Serneels, L., Umans, L., Schrijvers, V., Checler, F., Vanderstichele, H., Baekelandt, V., Dressel, R., Cupers, P., Huylebroeck, D., Zwijsen, A., Van Leuven, F. & De Strooper, B. (1999) Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc Natl Acad Sci USA 96, 11872-11877.
41. Holcomb, L.A., Gordon, M.N., Jantzen, P., Hsiao, K., Duff, K. & Morgan, D. (1999) Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav Genet 29, 177-185.
42. Holcomb, L., Gordon, M.N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, L, Mueller, R., Morgan, D., Sanders, S., Zehr, C., O'Campo, K., Hardy, J., Prada, C.M., Eckman, C., Younkin, S., Hsiao, K. & Duff, K. (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4, 97-100.
43. Hsia, A.Y., Masliah, E., McConlogue, L., Yu, G.Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R.C., Nicoll, R.A. & Mucke, L. (1999) Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci USA 96, 3228-3233.
44. Hsiao, K.K., Borchelt, D.R., Olson, K., Johannsdottir, R., Kitt, C., Yunis, W., Xu, S., Eckman, C., Younkin, S. & Price, D. (1995) Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15, 1203-1218.
45. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F. & Cole, G. (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102.
46. Huang, X.G., Yee, B.K., Nag, S., Chan, S.T. & Tang, F. (2003) Behavioral and neurochemical characterization of transgenic mice carrying the human presenilin-1 gene with or without the leucine-to-proline mutation at codon 235. Exp Neurol 183, 673-681.
47. Huitron-Resendiz, S., Sanchez-Alavez, M., Gallegos, R., Berg, G., Crawford, E., Giacchino, J.L., Games, D., Henriksen, S.J. & Criado, J.R. (2002) Age-independent and age-related deficits in visuospatial learning, sleep-wake states, thermoregulation and motor activity in PDAPP mice. Brain Res 928, 126-137.
48. Huppert, S.S., Le, A., Schroeter, E.H., Mumm, J.S., Saxena, M.T., Milner, L.A. & Kopan, R. (2000) Embryonic lethality in mice homozygous for a processing-deficient allele of Notch1. Nature 405, 966-970.
49. Hussain, I., Powell, D., Howlett, D.R., Tew, D.G., Meek, T.D., Chapman, C., Gloger, I.S., Murphy, K.E., Southan, C.D., Ryan, D.M., Smith, T.S., Simmons, D.L., Walsh, F.S., Dingwall, C. & Christie, G. (1999) Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol Cell Neurosci 14, 419-427.
50. Hwang, D.Y., Chae, K.R., Kang, T.S., Hwang, J.H., Lim, C.H., Kang, H.K., Goo, J.S., Lee, M.R., Lim, H.J., Min, S.H., Cho, J.Y., Hong, J.T., Song, C.W., Paik, S.G., Cho, J.S. & Kim, Y.K. (2002) Alterations in behavior, amyloid beta-42, caspase-3, and Cox-2 in mutant PS2 transgenic mouse model of Alzheimer's disease. Faseb J 16, 805-813.
51. Irizarry, M.C., Soriano, F., McNamara, M., Page, K.J., Schenk, D., Games, D. & Hyman, B.T. (1997) Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J Neurosci 17, 7053-7059.
52. Janus, C., D'Amelio, S., Amitay, O., Chishti, M.A., Strome, R., Fraser, P., Carlson, G.A., Roder, J.C., St George-Hyslop, P. & Westaway, D. (2000a) Spatial learning in transgenic mice expressing human presenilin 1 (PS1) transgenes. Neurobiol Aging 21, 541-549.
53. Janus, C., Pearson, J., McLaurin, J., Mathews, P.M., Jiang, Y., Schmidt, S.D., Chishti, M.A., Horne, P., Heslin, D., French, J., Mount, H.T., Nixon, R.A., Mercken, M., Bergeron, C., Fraser, P.E., St George-Hyslop, P. & Westaway, D. (2000b) A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408, 979-982.
54. Justice, A. & Motter, R. (1997) Behavioral characterization of PDAPP Alzheimer mice. Soc Neurosci 23, 1637.
55. Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S. & Malinow, R. (2003) APP processing and synaptic function. Neuron 37, 925-937.
56. Karkkainen, I., Rybnikova, E., Pelto-Huikko, M., Huovila & A.P. (2000) Metalloprotease-disintegrin (ADAM) genes are widely and differentially expressed in the adult CNS. Mol Cell Neurosci 15, 547-560.
57. Kelly, P.H., Bondolfi, L., Hunziker, D., Schlecht, H.P., Carver, K., Maguire, E., Abramowski, D., Wiederhold, K.H., Sturchler-Pierrat, C., Jucker, M., Bergmann, R., Staufenbiel, M. Sommer, B. (2003) Progressive age-related impairment of cognitive behavior in APP23 transgenic mice. Neurobiol Aging 24, 365-378.
58. Kelly, P.H., Hunziker, D., Schlecht, H.P., Carver, K., Abramowski, D., Sturchler-Pierrat, C., Staufenbiel, M. & Sommer, B. (1999) Progressive behavioural impairment in amyloid precursor protein transgenic mouse line APP23. Soc Neurosci 25, 519.
59. King, D.L. & Arendash, G.W. (2002a) Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19months. Physiol Behav 75, 627-642.
60. King, D.L. & Arendash, G.W. (2002b) Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging; correlations with cognitive impairment. Brain Res 326, 58-68.
61. King, D.L., Arendash, G.W., Crawford, F., Sterk, T., Menendez, J. & Mullan, M.J. (1999) Progressive and gender-dependent cognitive impairment in the APP (SW) transgenic mouse model for Alzheimer's disease, Behav Brain Res 103, 145-162.
62. Kotilinek, L.A., Bacskai, B., Westerman, M., Kawarabayashi, T., Younkin, L., Hyman, B.T., Younkin, S. & Ashe, K.H. (2002) Reversible memory loss in a mouse transgenic model of Alzheimer's disease. J Neurosci 22, 6331-6335.
63. Lai, K.O. & Ip, N.Y. (2003) Postsynaptic signaling of new players at the neuromuscular junction. J Neurocytol 32, 727-741.
64. Lalonde, R., Dumont, M., Staufenbiel, M., Sturchler-Pierrat, C. & Strazielle, C. (2002) Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation. Brain Res 956, 36-44.
65. Lalonde, R., Qian, S. & Strazielle, C. (2003a) Transgenic mice expressing the PS1-A246E mutation: effects on spatial learning, exploration, anxiety, and motor coordination. Behav Brain Res 138, 71-79.
66. Lalonde, R., Lewis, T.L., Strazielle, C., Kim, H. & Fukuchi, K. (2003b) Transgenic mice expressing the betaAPP695SWE mutation: effects on exploratory activity, anxiety, and motor coordination. Brain Res 977, 38-45.
67. Lambert, M.P., Barlow, A.K., Chromy, B.A., Edwards, C., Freed, R., Liosatos, M., Morgan, T.E., Rozovsky, I., Trommer, B., Viola, K.L., Wals, P., Zhang, C., Finch, C.E., Krafft, G.A. & Klein, W.L. (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95, 6448-6453.
68. Lammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., Haass, C. & Fahrenholz, F. (1999) Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci USA 96, 3922-3927.
69. Larson, J., Lynch, G., Games, D. & Seubert, P. (1999) Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res 840, 23-35.
70. Li, R., Lindholm, K., Yang, L.B., Yue, X., Citron, M., Van, R., Beach, T., Sue, L., Sabbagh, M., Cai, H., Wong, P., Price, D. & Shen, Y. (2004) Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients. Proc Natl Acad Sci USA 101, 3632-3637.
71. Liu, L., Tapiola, T., Herukka, S.K., Heikkila, M. & Tanila, H. (2003) Abeta levels in serum, CSF and brain, and cognitive deficits in APP + PS1 transgenic mice. Neuroreport 14, 163-166.
72. Luo, Y., Bolon, B., Damore, M.A., Fitzpatrick, D., Liu, H., Zhang, J., Yan, Q., Vassar, R. & Citron, M. (2003) BACE1 (betα-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time. Neurobiol Dis 14, 81-88.
73. Luo, Y., Bolon, B., Kahn, S., Bennett, B.D., Babu-Khan, S., Denis, P., Fan, W., Kha, H., Zhang, J., Gong, Y., Martin, L., Louis, J.C., Yan, Q., Richards, W.G., Citron, M. & Vassar, R. (2001) Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat Neurosci 4, 231-232.
74. Masliah, E., Sisk, A., Mallory, M., Mucke, L., Schenk, D. & Games, D. (1996) Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. J Neurosci 16, 5795-5811.
75. Masters, C.L., Simms, G., Weinman, N.A., Multhaup, G., McDonald, B.L. & Beyreuther, K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82, 4245-4249.
76. Mattson, M.P. (1997) Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev 77, 1081-1132.
77. McCool, M.F., Varty, G.B., Del Vecchio, R.A., Kazdoba, T.M., Parker, E.M., Hunter, J.C. & Hyde, L.A. (2003) Increased auditory startle response and reduced prepulse inhibition of startle in transgenic mice expressing a double mutant form of amyloid precursor protein. Brain Res 994, 99-106.
78. Moechars, D., Lorent, K., De Strooper, B., Dewachter, I. & Van Leuven, F. (1996) Expression in brain of amyloid precursor protein mutated in the alphα-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J 15, 1265-1274.
79. Moechars, D., Lorent, K. & Van Leuven, F. (1999) Premature death in transgenic mice that overexpress a mutant amyloid precursor protein is preceded by severe neurodegeneration and apoptosis. Neuroscience 91, 819-830.
80. Mohajeri, M.H., Saini, K.D. & Nitsch, R.M. (2004) Transgenic BACE expression in mouse neurons accelerates amyloid plaque pathology. J Neural Transm 111, 413-425.
81. Morgan, D., Diamond, D.M., Gottschall, P.E., Ligen, K.E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., Connor, K., Hatcher, J., Hope, C., Gordon, M. & Arendash, G.W. (2000) A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408, 982-985.
82. Mueggler, T., Sturchler-Pierrat, C., Baumann, D., Rausch, M., Staufenbiel, M. & Rudin, M. (2002) Compromised hemodynamic response in amyloid precursor protein transgenic mice. J Neurosci 22, 7218-7224.
83. Naslund, J., Jensen, M., Tjernberg, L.O., Thyberg, J., Terenius, L. & Nordstedt, C. (1994) The metabolic pathway generating p3, an A beta-peptide fragment, is probably non-amyloidogenic. Biochem Biophys Res Commun 204, 780-787.
84. Ohno, M., Sametsky, E.A., Younkin, L.H., Oakley, H., Younkin, S.G., Citron, M., Vassar, R. & Disterhoft, J.F. (2004) BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease. Neuron 41, 27-33.
85. Palop, J.J., Jones, B., Kekonius, L., Chin, J., Yu, G.Q., Raber, J., Masliah, E. & Mucke, L. (2003) Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits. Proc Natl Acad Sci USA 100, 9572-9577.
86. Peschon, J.J., Slack, J.L., Reddy, P., Stocking, K.L., Sunnarborg, S.W., Lee, D.C., Russell, W.E., Castner, B.J., Johnson, R.S., Fitzner, J.N., Boyce, R.W., Nelson, N., Kozlosky, C.J., Wolfson, M.F., Rauch, C.T., Cerretti, D.P., Paxton, R.J., March, C.J. & Black, R.A. (1998) An essential role for ectodomain shedding in mammalian development. Science 282, 1281-1284.
87. Pettit, D.L., Shao, Z. & Yakel, J.L. (2001) Beta-amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice. J Neurosci 21, RC120.
88. Pompl, P.N., Mullan, M.J., Bjugstad, K. & Arendash, G.W. (1999) Adaptation of the circular platform spatial memory task for mice: use in detecting cognitive impairment in the APP (SW) transgenic mouse model for Alzheimer's disease. J Neurosci Methods 87, 87-95.
89. Postina, R., Schroeder, A., Dewachter, I., Bohl, J., Schmitt, U., Kojro, E., Prinzen, C., Endres, K., Hiemke, C., Blessing, M., Flamez, P., Dequenne, A., Godaux, E., van Leuven, F. & Fahrenholz, F. (2004) A disintegrin- metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J Clin Invest 113, 1456-1464.
90. Rauch, T.M., Welch, D.I. & Gallego, L. (1989) Hypothermia impairs performance in the Morris water maze. Physiol Behav 46, 315-320.
91. Roberds, S.L., Anderson, J., Basi, G. et al. (2001) BACE knockout mice are healthy despite lacking the primary betα-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum Mol Genet 10, 1317-1324.
92. Routtenberg, A. (1997) Measuring memory in a mouse model of Alzheimer's disease. Science 277, 839-841.
93. Schenk, D., Barbour, R., Dunn, W. et al. (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173-177.
94. Seabrook, G.R., Smith, D.W., Bowery, B.J., Easter, A., Reynolds, T., Fitzjohn, S.M., Morton, R.A., Zheng, H., Dawson, G.R., Sirinathsinghji, D.J., Davies, C.H., Collingridge, G.L. & Hill, R.G. (1999) Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor, protein. Neuropharmacology 38, 349-359.
95. Selkoe, D.J. (1991) The molecular pathology of Alzheimer's disease. Neuron 6, 487-498.
96. Sennvik, K., Fastbom, J., Blomberg, M., Wahlund, L.O., Winblad, B. & Benedikz, E. (2000) Levels of alpha- and betα-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients. Neurosci Lett 278, 169-172.
97. Shen, J., Bronson, R.T., Chen, D.F., Xia, W., Selkoe, D.J. & Tonegawa, S. (1997) Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 89, 629-639.
98. Sinha, S., Anderson, J.P., Barbour, R. et al. (1999) Purification and cloning of amyloid precursor protein betα-secretase from human brain. Nature 402, 537-540.
99. Small, D.H., Clarris, H.L, Williamson, T.G., Reed, G., Key, B., Mok, S.S., Beyreuther, K., Masters, C.L. & Nurcombe, V. (1999) Neurite-outgrowth regulating functions of the amyloid protein precursor of Alzheimer's disease. J Alzheimers Dis 1, 275-285.
100. Steinbach, J.P., Muller, U., Leist, M., Li, Z.W., Nicotera, P. & Aguzzi, A. (1998) Hypersensitivity to seizures in beta-amyloid precursor protein deficient mice. Cell Death Differ 5, 858-866.
101. Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.H., Mistl, C., Rothacher, S., Ledermann, B., Burki, K., Frey, P., Paganetti, P.A., Waridel, C., Calhoun, M.E., Jucker, M., Probst, A., Staufenbiel, M. & Sommer, B. (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94, 13287-13292.
102. Swiatek, P.J., Lindsell, C.E., del Amo, F.F., Weinmaster, G. & Gridley, T. (1994) Notch1 is essential for postimplantation development in mice. Genes Dev 8, 707-719.
103. Takeuchi, A., Irizarry, M.C., Duff, K., Saido, T.C., Hsiao Ashe, K., Hasegawa, M., Mann, D.M., Hyman, B.T. & Iwatsubo, T. (2000) Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss. Am J Pathol 157, 331-339.
104. Tomidokoro, Y., Harigaya, Y., Matsubara, E., Ikeda, M., Kawarabayashi, T., Shirao, T., Ishiguro, K., Okamoto, K., Younkin, S.G. & Shoji, M. (2001) Brain Abeta amyloidosis in APPsw mice induces accumulation of presenilin-1 and tau. J Pathol 194, 500-506.
105. Torroja, L., Chu, H., Kotovsky, I. & White, K. (1999) Neuronal over-expression of APPL, the Drosophila homologue of the amyloid precursor protein (APP), disrupts axonal transport. Curr Biol 9, 489-492.
106. Van Dam, D., D'Hooge, R., Staufenbiel, M., Van Ginneken, C., Van Meir, F. & De Deyn, P.P. (2003) Age-dependent cognitive decline in the APP23 model precedes amyloid deposition. Eur J Neurosci 17, 388-396.
107. Vassar, R., Bennett, B.D., Babu-Khan, S. et al. (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741.
108. Walsh, D.M., Klyubin, I., Fadeeva, J.V., Cullen, W.K., Anwyl, R., Wolfe, M.S., Rowan, M.J. & Selkoe, D.J. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539.
109. Wang, H.W., Pasternak, J.F., Kuo, H., Ristic, H., Lambert, M.P., Chromy, B., Viola, K.L., Klein, W.L., Stine, W.B., Krafft, G.A. & Trommer, B.L. (2002) Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res 924, 133-140.
110. Wei, W., Norton, D.D., Wang, X. & Kusiak, J.W. (2002) Abeta 17-42 in Alzheimer's disease activates JNK and caspase-8 leading to neuronal apoptosis. Brain 125, 2036-2043.
111. Weiss, C., Venkatasubramanian, P.N., Aguado, A.S., Power, J.M., Tom, B.C., Li, L., Chen, K.S., Disterhoft, J.F. & Wyrwicz, A.M. (2002) Impaired eyeblink conditioning and decreased hippocampal Volume in PDAPP V717F mice. Neurobiol Dis 11, 425-433.
112. Weskamp, G., Cai, H., Brodie, T.A., Higashiyama, S., Manova, K., Ludwig, T. & Blobel, C.P. (2002) Mice lacking the metalloproteinase-disintegrin MDC9 (ADAM9) have no major abnormalities during development to adult life. Mol Cell Biol 22, 1537-1544.
113. Westerman, M.A., Cooper-Blacketer, D., Mariash, A., Kotilinek, L., Kawarabayashi, T., Younkin, L.H., Carlson, G.A., Younkin, S.G. & Ashe, K.H. (2002) The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci 22, 1858-1867.
114. Wild-Bode, C., Yamazaki, T., Capell, A., Leimer, U., Steiner, H., Ihara, Y. & Haass, C. (1997) Intracellular generation and accumulation of amyloid beta-peptide terminating at amino acid 42. J Biol Chem 272, 16085-16088.
115. Winkler, D.T., Bondolfi, L., Herzig, M.C., Jann, L., Calhoun, M.E., Wiederhold, K.H., Tolnay, M., Staufenbiel, M. & Jucker, M. (2001) Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. J Neurosci 21, 1619-1627.
116. Wolfer, D.P. & Lipp, H.P. (2000) Dissecting the behaviour of transgenic mice: is it the mutation, the genetic background, or the environment? Exp Physiol 85, 627-634.
117. Yan, R., Bienkowski, M.J., Shuck, M.E., Miao, H., Tory, M.C., Pauley, A.M., Brashier, J.R., Stratman, N.C., Mathews, W.R., Buhl, A.E., Carter, D.B., Tomasselli, A.G., Parodi, L.A., Heinrikson, R.L. & Gurney, M.E. (1999) Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402, 533-537.
118. Yu, H., Saura, C.A., Choi, S.Y., Sun, L.D., Yang, X., Handler, M., Kawarabayashi, T., Younkin, L., Fedeles, B., Wilson, M.A., Younkin, S., Kandel, E.R., Kirkwood, A. & Shen, J. (2001) APP processing and synaptic plasticity in presenilin-1 conditional knockout mice. Neuron 31, 713-726.
119. Zheng, H., Jiang, M., Trumbauer, M.E., Sirinathsinghji, D.J., Hopkins, R., Smith, D.W., Heavens, R.P., Dawson, G.R., Boyce, S. & Conner, M.W. (1995) beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 81, 525-531.